Fabian Gerlinghaus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bristol Myers Squibb seals $380M CAR-T therapy production deal

With equipment that promises to produce 10 times more therapies, the deal with Cellares is hoped to make BSM's CAR-T ambitions more scalable and affordable

Bristol myers squibbFabian gerlinghausManufacturing organizationCell shuttleSmart factoriesCellare cell shuttleIntegrated developmentCabaletta bioBio developmentsCell amp gene therapiesBristol myers squibbAr tCart cell therapy

BMS inks CAR T cell manufacturing deal with Cellares

BMS inks CAR T cell manufacturing deal with Cellares
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Fabian gerlinghausBristol myers squibbLynelle hochCellare technology adoption partnershipCell therapy organizationMyers squibbSmart factoryCell shuttle

Cellares, BMS announce $380M cell therapy manufacturing agreement

Cellares, BMS announce $380M cell therapy manufacturing agreement
njbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njbiz.com Daily Mail and Mail on Sunday newspapers.

Lynelle hochOmar kurdiFabian gerlinghausBristol myers squibbManufacturing organizationTechnology adoption partnershipCell therapy organizationMyers squibbIntegrated developmentSmart factoryCell shuttleSmart factoriesPresident omar kurdiBristol myers

Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster

Bristol Myers Squibb will utilize Cellares’ proprietary Cell Shuttle, a next-generation end-to-end, fully automated cell therapy manufacturing platform, for the clinical and commercial-scale.

New jerseyUnited statesSouth san franciscoBristol myers squibbFabian gerlinghausLynelleb hochCellare technology adoption partnershipCell therapy organizationManufacturing organizationExchange commissionIntegrated developmentCell shuttleCell shuttlesCellare smart factoriesBristol myersSmart factories

Bristol-Myers Squibb (BMY) and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies

Bristol-Myers Squibb (BMY) and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Fabian gerlinghausBristol myers squibbLynelleb hochCellare technology adoption partnershipCell therapy organizationManufacturing organizationIntegrated developmentCell shuttleCell shuttlesCellare smart factoriesBristol myersSmart factories